BCL2 and diffuse large B-cell lymphoma: Importantly, all of those cases were double protein expressors, highlighting the ability of MYC/BCL2 IHC to catch a few of the aggressive GCB-type DLBCL tumors that are falsely negative by breakapart FISH [76].